StonvexLoading…
StonvexStonvexStonvexCore line items from OMSE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-06-15 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $203.61M | $163.27M | $18.18M | $97.46M |
Operating Income | $59.87M | $40.17M | $3.24M | $19.90M |
Net Income | $46.98M | $82.09M | $2.38M | $12.42M |
EPS (Diluted) | $1.18 | $2.19 | Not available | $5291.07 |
Total Assets | $170.50M | $153.43M | Not available | $100.11M |
Total Liabilities | $35.92M | $73.08M | Not available | $65.97M |
Cash & Equivalents | $72.95M | $43.47M | $27.67M | $29.53M |
Free Cash Flow OCF − CapEx | $37.64M | $20.81M | $-4.09M | $27.96M |
Shares Outstanding | 38.74M | 36.90M | Not available | Not available |